Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CUPR
CUPR logo

CUPR News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CUPR News

Biotech Companies See Significant Stock Gains

Jul 01 2026NASDAQ.COM

Pulsenmore Soars 280% on Ouma Health Collaboration

Jun 25 2026NASDAQ.COM

Biotech Sector Sees FDA Approvals and Layoffs

Jun 19 2026NASDAQ.COM

Biotech Stocks Show Significant Pre-Market Activity

Jun 16 2026NASDAQ.COM

Cuprina Secures FDA Clearance for MEDIFLY, Shares Surge Over 110%

Jun 16 2026NASDAQ.COM

Regentis Soars After Withdrawing US Listing Application

Jun 16 2026NASDAQ.COM

Cuprina Secures FDA Approval for New Maggot Therapy Product

Jun 15 2026stocktwits

Cuprina Secures FDA 510(k) Clearance for MEDIFLY Maggots™

Jun 15 2026Newsfilter

CUPR Events

07/07 13:00
R. F. Lafferty & Co. Acts as Underwriter
R. F. Lafferty & Co. is acting as the underwriter for the offering.
06/15 09:30
Cuprina Holdings Receives FDA Clearance for Medifly Maggots
Cuprina Holdings announced that an indirectly wholly-owned subsidiary of the company, Cuprina Pte. has received 510 clearance from the FDA for Medifly Maggots, its medical-grade Lucilia cuprina larvae used in maggot debridement therapy.
05/29 13:00
Cuprina Holdings Completes Reverse Stock Split, Requests Nasdaq Hearing
Cuprina Holdings announced that it completed a reverse stock split on May 27, 2026, and requested a hearing before the Nasdaq Hearings Panel, in response to a staff determination letter received on May 27, 2026, from the Listing Qualifications Department of the Nasdaq Stock Market LLC. The Letter notified the company that, due to the company's failure to regain compliance with a minimum bid price of $1.00 per share requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2), Nasdaq has determined that company's securities will be scheduled for delisting from Nasdaq unless the company requests an appeal of the Determination to a Panel. On November 26, 2025, the company received a notice from Nasdaq, notifying the company that based upon the closing bid price of its securities for the last 30 consecutive business days preceding the Notice, the company was not in compliance with the Minimum Bid Requirement. In accordance with Listing Rule 5810(c)(3)(a), the Notice provided the company a period of 180 calendar days from the date of the Notice, or until May 26, 2026, to regain compliance with the Minimum Bid Requirement. According to the Letter, the company had not regained compliance with the Minimum Bid Requirement as of May 26, 2026. Unless the company requests an appeal of the Determination by June 3, 2026 to the Panel, the company's securities will be suspended at the opening of business on June 5, 2026, and a Form 25-NSE will be filed with the U.S. Securities and Exchange Commission, which will remove the company's securities from listing and registration on Nasdaq. The company has proactively completed the share consolidation on May 27, 2026, which is expected to bring the company's bid price into compliance with the Minimum Bid Requirement. The company remains committed to maintaining its Nasdaq listing and will provide its shareholders with material updates when they are available.

CUPR Monitor News

Cuprina Holdings Surges as Stock Crosses Above 5-Day SMA

Jun 30 2026

Cuprina Holdings surges as market strengthens amid FDA approvals

Jun 24 2026

Cuprina Holdings Regains Nasdaq Compliance, Boosting Investor Confidence

Jun 15 2026

Cuprina Holdings reaches 5-day high amid market fluctuations

Jun 12 2026

Cuprina Holdings falls as market declines

Jun 10 2026

Cuprina Holdings Announces 1-for-8 Share Consolidation Plan

May 28 2026

Cuprina Holdings surges after crossing above key SMA

May 13 2026

Cuprina Holdings reaches 20-day high amid market gains

Apr 07 2026

CUPR Earnings Analysis

No Data

No Data

People Also Watch